Search

Your search keyword '"Fischerova, D."' showing total 573 results
Start Over Author "Fischerova, D."
573 results on '"Fischerova, D."'

151. A novel approach to predict the likelihood of specific ovarian tumor pathology based on serum CA-125: a multicenter observational study

Author

Van Calster, B., Timmerman, D., Testa, Antonia Carla, Valentin, L., Van Holsbeke, Cd, Zhang, J, Jurkovic, D, Lissoni, Aa, Czekierdowski, A, Fischerova, D, Domali, E, Van De Putte, G, Vergote, I, Van Huffel, S, Bourne, T., Testa, Antonia Carla (ORCID:0000-0003-2217-8726), Van Calster, B., Timmerman, D., Testa, Antonia Carla, Valentin, L., Van Holsbeke, Cd, Zhang, J, Jurkovic, D, Lissoni, Aa, Czekierdowski, A, Fischerova, D, Domali, E, Van De Putte, G, Vergote, I, Van Huffel, S, Bourne, T., and Testa, Antonia Carla (ORCID:0000-0003-2217-8726)

Abstract

BACKGROUND: The CA-125 tumor marker has limitations when used to distinguish between benign and malignant ovarian masses. We therefore establish likelihood curves of six subgroups of ovarian pathology based on CA-125 and menopausal status. METHODS: This cross-sectional study conducted by the International Ovarian Tumor Analysis group involved 3,511 patients presenting with a persistent adnexal mass that underwent surgical intervention. CA-125 distributions for six tumor subgroups (endometriomas and abscesses, other benign tumors, borderline tumors, stage I invasive cancers, stage II-IV invasive cancers, and metastatic tumors) were estimated using kernel density estimation with stratification for menopausal status. Likelihood curves for the tumor subgroups were derived from the distributions. RESULTS: Endometriomas and abscesses were the only benign pathologies with median CA-125 levels above 20 U/mL (43 and 45, respectively). Borderline and invasive stage I tumors had relatively low median CA-125 levels (29 and 81 U/mL, respectively). The CA-125 distributions of stage II-IV invasive cancers and benign tumors other than endometriomas or abscesses were well separated; the distributions of the other subgroups overlapped substantially. This held for premenopausal and postmenopausal patients. Likelihood curves and reference tables comprehensibly show how subgroup likelihoods change with CA-125 and menopausal status.Conclusions and Impact: Our results confirm the limited clinical value of CA-125 for preoperative discrimination between benign and malignant ovarian pathology. We have shown that CA-125 may be used in a different way. By using likelihood reference tables, we believe clinicians will be better able to interpret preoperative serum CA-125 results in patients with adnexal masses. Cancer Epidemiol Biomarkers Prev; ©2011 AACR.

Published
2011

152. Risk of malignancy in unilocular cysts: a study of 1148 adnexal masses classified as unilocular cysts at transvaginal ultrasound and review of the literature.

Author

Valentin L, Ameye L, Franchi D, Guerriero S, Jurkovic D, Savelli L, Fischerova D, Lissoni A, Van Holsbeke C, Fruscio R, Van Huffel S, Testa A, Timmerman D, Valentin, L, Ameye, L, Franchi, D, Guerriero, S, Jurkovic, D, Savelli, L, and Fischerova, D

Abstract

Objectives: The aim of this study was to estimate the rate of malignancy in adnexal lesions described as unilocular cysts at transvaginal ultrasound examination and to investigate if there are differences in clinical and ultrasound characteristics between benign and malignant unilocular cysts. Methods: A total of 3511 patients with an adnexal mass underwent transvaginal ultrasound examination between 1999 and 2007. Sonologists used the International Ovarian Tumor Analysis terms and definitions to describe their ultrasound findings. Only masses operated on within 120  days after the ultrasound examination were included in the analysis and the histopathological diagnosis of the mass was used as the gold standard. Results: Of the 3511 masses, 1148 (33%) were classified as unilocular cysts on ultrasound. Of these, 11 (0.96% (95% CI, 0.48-1.71)) were malignant. The malignancy rate was lower in premenopausal than in postmenopausal women: 0.54% (5/931; 95% CI, 0.17-1.25) vs. 2.76% (6/217; 95% CI, 1.02-5.92); P = 0.009. More patients with malignant unilocular cysts had a personal history of breast cancer (18% vs. 2%; P = 0.02) or ovarian cancer (18% vs 0.6%; P = 0.003). Hemorrhagic cyst contents on ultrasound were more common in malignant than in benign unilocular cysts (18% vs. 2%; P = 0.03). In seven of the 11 malignancies judged to be unilocular cysts at scan, papillary projections or other solid components were seen at macroscopic inspection of the surgical specimen. Conclusions: The malignancy rate in surgically removed adnexal lesions judged to be unilocular cysts at transvaginal scan is c 1%. Postmenopausal status, personal history of breast or ovarian cancer and hemorrhagic cyst contents on ultrasound increase the risk of malignancy. To avoid misclassifying adnexal lesions as unilocular cysts at scan, it is important to scrutinize unilocular cysts for the presence of solid components. [ABSTRACT FROM AUTHOR]

Published
2013
Full Text
View/download PDF

153. Endometriomas: their ultrasound characteristics.

Author

Van Holsbeke, C, Van Calster, Ben, Guerriero, S, Savelli, L, Paladini, D, Lissoni, A, Czkierdowski, A, Fischerova, D, Zhang, J, Mestdagh, G, Testa, Antonia Carla, Bourne, T, Valentin, L, Timmerman, D., Testa, Antonia Carla (ORCID:0000-0003-2217-8726), Van Holsbeke, C, Van Calster, Ben, Guerriero, S, Savelli, L, Paladini, D, Lissoni, A, Czkierdowski, A, Fischerova, D, Zhang, J, Mestdagh, G, Testa, Antonia Carla, Bourne, T, Valentin, L, Timmerman, D., and Testa, Antonia Carla (ORCID:0000-0003-2217-8726)

Abstract

OBJECTIVES: To describe the ultrasound characteristics of endometriomas in pre- and postmenopausal patients and to develop rules that characterize endometriomas. METHODS: All patients included in the International Ovarian Tumor Analysis (IOTA) studies were used in our analysis. Patients with an adnexal mass were scanned by experienced sonologists using a standardized research protocol. The gold standard was the histology of the surgically removed adnexal mass. The gray-scale and Doppler ultrasound characteristics of the endometriomas were compared with those of other benign and malignant masses. Based on decision-tree analysis, the existing literature and clinical experience, ultrasound rules for the detection of endometriomas were created and evaluated. RESULTS: Of all 3511 patients included in the IOTA studies, 713 (20%) had endometriomas. Fifty-one per cent of the endometriomas were unilocular cysts with ground glass echogenicity of the cyst fluid. These characteristics were found less often among other benign tumors or malignancies, or among the small set of endometriomas (4%) that were found in postmenopausal patients. Based on the decision-tree analysis, the optimal rule to detect endometriomas was 'an adnexal mass in a premenopausal patient with ground glass echogenicity of the cyst fluid, one to four locules and no papillations with detectable blood flow'. Based on clinical considerations, the following rule: 'premenopausal status, ground glass echogenicity of the cyst fluid, one to four locules and no solid parts' seems preferable. CONCLUSIONS: Several rules had a good ability to characterize endometriomas. The ultrasound characteristics of endometriomas differ between pre- and postmenopausal patients. Masses in postmenopausal women whose cystic contents have a ground glass appearance have a high risk of malignancy.

Published
2010

154. Simple ultrasound rules to distinguish between benign and malignant adnexal masses before surgery: prospective validation by IOTA group

Author

Timmerman, D, Ameye, L, Fischerova, D, Epstein, E, Melis, G, Guerriero, S, Van Holsbeke, C, Savelli, L, Fruscio, R, Lissoni, A, Testa, A, Veldman, J, Vergote, I, Van Huffel, S, Bourne, T, Valentin, L, Melis, GB, FRUSCIO, ROBERT, LISSONI, ANDREA ALBERTO, Testa, AC, Valentin, L., Timmerman, D, Ameye, L, Fischerova, D, Epstein, E, Melis, G, Guerriero, S, Van Holsbeke, C, Savelli, L, Fruscio, R, Lissoni, A, Testa, A, Veldman, J, Vergote, I, Van Huffel, S, Bourne, T, Valentin, L, Melis, GB, FRUSCIO, ROBERT, LISSONI, ANDREA ALBERTO, Testa, AC, and Valentin, L.

Abstract

To prospectively assess the diagnostic performance of simple ultrasound rules to predict benignity/malignancy in an adnexal mass and to test the performance of the risk of malignancy index, two logistic regression models, and subjective assessment of ultrasonic findings by an experienced ultrasound examiner in adnexal masses for which the simple rules yield an inconclusive result. Prospective temporal and external validation of simple ultrasound rules to distinguish benign from malignant adnexal masses. The rules comprised five ultrasonic features (including shape, size, solidity, and results of colour Doppler examination) to predict a malignant tumour (M features) and five to predict a benign tumour (B features). If one or more M features were present in the absence of a B feature, the mass was classified as malignant. If one or more B features were present in the absence of an M feature, it was classified as benign. If both M features and B features were present, or if none of the features was present, the simple rules were inconclusive. 19 ultrasound centres in eight countries. 1938 women with an adnexal mass examined with ultrasound by the principal investigator at each centre with a standardised research protocol. Reference standard Histological classification of the excised adnexal mass as benign or malignant. Diagnostic sensitivity and specificity. Of the 1938 patients with an adnexal mass, 1396 (72%) had benign tumours, 373 (19.2%) had primary invasive tumours, 111 (5.7%) had borderline malignant tumours, and 58 (3%) had metastatic tumours in the ovary. The simple rules yielded a conclusive result in 1501 (77%) masses, for which they resulted in a sensitivity of 92% (95% confidence interval 89% to 94%) and a specificity of 96% (94% to 97%). The corresponding sensitivity and specificity of subjective assessment were 91% (88% to 94%) and 96% (94% to 97%). In the 357 masses for which the simple rules yielded an inconclusive result and with available results of

Published
2010

155. Ovarian cancer prediction in adnexal masses using ultrasound based logistic regression models: a temporal and external validation study by the IOTA group

Author

Timmerman, D, Van Calster, B, Testa, A, Guerriero, S, Fischerova, D, Lissoni, A, Van Holsbeke, C, Fruscio, R, Czekierdowski, A, Jurkovic, D, Savelli, L, Vergote, I, Bourne, T, Van Huffel, S, Valentin, L, Testa, AC, LISSONI, ANDREA ALBERTO, FRUSCIO, ROBERT, Valentin, L., Timmerman, D, Van Calster, B, Testa, A, Guerriero, S, Fischerova, D, Lissoni, A, Van Holsbeke, C, Fruscio, R, Czekierdowski, A, Jurkovic, D, Savelli, L, Vergote, I, Bourne, T, Van Huffel, S, Valentin, L, Testa, AC, LISSONI, ANDREA ALBERTO, FRUSCIO, ROBERT, and Valentin, L.

Abstract

OBJECTIVE: To temporally and externally validate the diagnostic performance of two logistic regression models containing clinical and ultrasound variables to estimate the risk of malignancy in adnexal masses, and to compare them with the subjective interpretation of ultrasound findings by an experienced ultrasound examiner ("subjective assessment"). METHODS: Patients with adnexal masses from 19 centers underwent a standardized transvaginal ultrasound examination by a gynecologist or radiologist specialized in ultrasonography. The examiner prospectively collected information on clinical and ultrasound variables, and classified each mass as benign or malignant on the basis of subjective evaluation of ultrasound findings. The gold standard was the histology of the mass with local clinicians deciding whether to operate on the basis of ultrasound results and clinical picture. The models' ability to discriminate between malignant and benign masses was assessed, as well as the accuracy of the risk estimates. RESULTS: 1938 patients were included; 1396 benign, 373 primary invasive, 111 borderline malignant, and 58 metastatic tumors. On external validation (997 patients from 12 centers), the area under the receiver operating characteristic curve (AUC) for a model containing 12 predictors (LR1) was 0.956, for a reduced model with six predictors (LR2) 0.949, and for subjective assessment 0.949. Subjective assessment gave a positive likelihood ratio of 11.0 and a negative likelihood ratio of 0.14. The corresponding likelihood ratios for a previously derived probability threshold (0.1) were 6.84 and 0.09 for LR1, and 6.36, and 0.10 for LR2. On temporal validation (941 patients from seven centers) the AUCs were 0.945 (LR1), 0.918 (LR2), and 0.959 (subjective assessment). CONCLUSIONS: Both models provide excellent discrimination between benign and malignant masses. Because the models provide an objective and fairly accurate risk estimation, they may improve the management of women

Published
2010

156. The value of the 'ovarian crescent sign' to exclude an invasive malignancy.

Author

Journal of Ultrasound in Obstetrics and Gynecology, Van Holsbeke, C, Czekierdowski, A, Fischerova, D, Jingzhang, Z, De Jonge, E, Jurkovic, D, Paladini, D, Testa, Antonia Carla, Timmerman, D., Testa, Antonia Carla (ORCID:0000-0003-2217-8726), Journal of Ultrasound in Obstetrics and Gynecology, Van Holsbeke, C, Czekierdowski, A, Fischerova, D, Jingzhang, Z, De Jonge, E, Jurkovic, D, Paladini, D, Testa, Antonia Carla, Timmerman, D., and Testa, Antonia Carla (ORCID:0000-0003-2217-8726)

Abstract

Aim To examine the value of the “ovarian crescent sign” - a rim of normal ovarian tissue adjacent to an ipsilateral adnexal mass - as a sonographic feature to exclude an invasive malignancy. Methods During the IOTA phase 2 study, patients with an adnexal mass were included in 19 different international centers. All patients were scanned following the same standardized ultrasound protocol. The primary outcome was the histological diagnosis. More than 40 demographic and ultrasound variables were mandatory, but the evaluation of the “ovarian crescent sign” was optional. The ovarian crescent sign is assumed to exclude an invasive malignancy, therefore benign and borderline tumors were analyzed as one group. Results 1940 patients were included but the “ovarian crescent sign” was evaluated only in 1476 cases (76%) of which 1016 (69%) were benign and 460 (31%) malignant: 319 masses (21.6%) were primary invasive, 92 (6.2%) borderline and 49 (3.3%) metastatic. The “ovarian crescent sign” was present in 464 masses (425 benign, 20 primary invasive, 17 borderline, 2 metastasis). 299 (94%) of the primary invasive masses had no ovarian crescent sign, but in 20 cases (6%) it was reported: 13 epithelial carcinomas (3 stage I, 1 stage II, 8 stage III, 1 stage IV), 3 rare malignancies (struma, teratoma, GCT) and 4 extra ovarian malignancies (2 tubal ca, 1 clear cell ca of the uterus and one peritoneal ca with normal ovaries). The sensitivity and specificity for absence of the “ovarian crescent sign” to detect an invasive malignancy was 94.0% and 39.9%, LR + was 1.56 and LR − 0.15. Conclusion This study confirms previous reports that in the presence of the “ovarian crescent sign” the risk of an invasive malignancy is low. As a single ultrasound variable it can not reliably discriminate between benign and malignant adnexal masses but in combination with other ultrasound variables it might prove to be valuable. This far no scoring system or mathematical model has used it as a variable.

Published
2008

157. The ability of four ultrasound methods to discriminate between benign and malignant tumors considered difficult to classify by ultrasound examiners.

Author

International Society of Ultrasound in Obstetrics and Gynecology, Valentin, L, Ameye, L, Savelli, L, Van Holsbeke, C, Fruscio, R, Testa, Antonia Carla (ORCID:0000-0003-2217-8726), Fischerova, D, Van Huffel, S, Paladini, D, Amant, F, Jurkovic, D, Timmerman, D., International Society of Ultrasound in Obstetrics and Gynecology, Valentin, L, Ameye, L, Savelli, L, Van Holsbeke, C, Fruscio, R, Testa, Antonia Carla (ORCID:0000-0003-2217-8726), Fischerova, D, Van Huffel, S, Paladini, D, Amant, F, Jurkovic, D, and Timmerman, D.

Abstract

N/A

Published
2008

158. Prospective comparison of one-step and two-step models for the classification of adnexal masses as benign or malignant

Author

International Society of Ultrasound in Obstetrics and Gynecology, Daeman, A, Van Holsbeke, C, Gevaert, O, Fruscio, R, Guerriero, S, Czekierdowski, A, Valentin, L, Savelli, L, Testa, Antonia Carla, Fischerova, D, Bourne, T, Vergote, I, De Moor, B, Timmerman, D., Testa, Antonia Carla (ORCID:0000-0003-2217-8726), International Society of Ultrasound in Obstetrics and Gynecology, Daeman, A, Van Holsbeke, C, Gevaert, O, Fruscio, R, Guerriero, S, Czekierdowski, A, Valentin, L, Savelli, L, Testa, Antonia Carla, Fischerova, D, Bourne, T, Vergote, I, De Moor, B, Timmerman, D., and Testa, Antonia Carla (ORCID:0000-0003-2217-8726)

Abstract

N/A

Published
2008

160. OC14.03: Clinical and ultrasound characteristics of tubal cancer

Author

Ludovisi, M., primary, De Blasis, I., additional, Virgilio, B., additional, Giansiracusa, C., additional, Fischerova, D., additional, Franchi, D., additional, Pascual, M., additional, Savelli, L., additional, Epstein, E., additional, Van Holsbeke, C., additional, Guerriero, S., additional, Czekierdowski, A., additional, Jurkovic, D., additional, Rossi, A., additional, Timmerman, D., additional, Mascilini, F., additional, Valentin, L., additional, and Testa, A., additional

Published
2013
Full Text
View/download PDF

162. OP14.07: Transvaginal ultrasound assessment of myometrial and cervical stroma invasion in endometrial cancer: can any gynecologist do the job?

Author

Jäger, L., primary, Lindqvist, P. G., additional, Flöter Rådestad, A., additional, Dueholm, M., additional, Fischerova, D., additional, Franchi, D., additional, Jokubkiene, L., additional, Leone, F., additional, Savelli, L., additional, Sladkevicius, P., additional, Testa, A., additional, Van den Bosch, T., additional, and Epstein, E., additional

Published
2013
Full Text
View/download PDF

164. Risk of malignancy in unilocular cysts: a study of 1148 adnexal masses classified as unilocular cysts at transvaginal ultrasound and review of the literature

Author

Valentin, L., primary, Ameye, L., additional, Franchi, D., additional, Guerriero, S., additional, Jurkovic, D., additional, Savelli, L., additional, Fischerova, D., additional, Lissoni, A., additional, Van Holsbeke, C., additional, Fruscio, R., additional, Van Huffel, S., additional, Testa, A., additional, and Timmerman, D., additional

Published
2012
Full Text
View/download PDF

167. OC24.01: Early stage cervical cancer: tumor delineation by magnetic resonance imaging and ultrasound in a preoperative staging, verified by pathological results: the results of an European multicentre trial

Author

Epstein, E., primary, Testa, A., additional, Gaurilcikas, A., additional, Di Legge, A., additional, Ameye, L., additional, Atstupenaite, V., additional, Valentini, A., additional, Gui, B., additional, Wallengren, N., additional, Pudaric, S., additional, Cizauskas, A., additional, Masback, A., additional, Zannoni, G., additional, Kannisto, P., additional, Zikan, M., additional, Pinkavova, I., additional, Burgetova, A., additional, Dundr, P., additional, Nemejcova, K., additional, Cibula, D., additional, and Fischerova, D., additional

Published
2012
Full Text
View/download PDF

174. Simple ultrasound rules to distinguish between benign and malignant adnexal masses before surgery: prospective validation by IOTA group

Author

Timmerman, D., primary, Ameye, L., additional, Fischerova, D., additional, Epstein, E., additional, Melis, G. B., additional, Guerriero, S., additional, Van Holsbeke, C., additional, Savelli, L., additional, Fruscio, R., additional, Lissoni, A. A., additional, Testa, A. C., additional, Veldman, J., additional, Vergote, I., additional, Van Huffel, S., additional, Bourne, T., additional, and Valentin, L., additional

Published
2010
Full Text
View/download PDF

176. OC23.02: Which histologies limit the ability of CA-125 to characterize adnexal masses? An observational study of 3511 patients

Author

Van Calster, B., primary, Van Holsbeke, C., additional, Zhang, J., additional, Jurkovic, D., additional, Lissoni, A. A., additional, Valentin, L. I., additional, Testa, A., additional, Czekierdowski, A., additional, Fischerova, D., additional, Van de Putte, G., additional, Vergote, I., additional, Van Huffel, S., additional, Bourne, T., additional, and Timmerman, D., additional

Published
2010
Full Text
View/download PDF

177. OC01.03: Ultrasound in diagnosis of new and recurrent borderline ovarian tumors

Author

Fischerova, D., primary, Franchi, D., additional, Testa, A., additional, Valentin, L. I., additional, Savelli, L., additional, Lissoni, A., additional, Fruscio, R., additional, Van Holsbeke, C., additional, De Jonge, E., additional, VanHuffel, S., additional, Bourne, T., additional, Van Calster, B., additional, Amant, F., additional, and Timmerman, D., additional

Published
2010
Full Text
View/download PDF

178. OC23.01: New logistic regression model to predict ovarian malignancy in cases for which simple ultrasound rules are not applicable

Author

Ameye, L., primary, Fischerova, D., additional, Valentin, L. I., additional, Epstein, E., additional, Leone, F., additional, Melis, G. B., additional, Guerriero, S., additional, Van Holsbeke, C., additional, Veldman, J., additional, Savelli, L., additional, Fruscio, R., additional, Lissoni, A., additional, Testa, A., additional, Vergote, I., additional, Van Huffel, S., additional, Van Calster, B., additional, and Timmerman, D., additional

Published
2010
Full Text
View/download PDF

180. OC25.01 Unilocular solid adnexal masses with papillary projections but no other solid components: is there a logistic regression model that can help?

Author

Valentin, L. I., primary, Ameye, L., additional, Savelli, L., additional, Fruscio, R., additional, Leone, F., additional, Czekierdowski, A., additional, Lissoni, A. A., additional, Fischerova, D., additional, Guerriero, S., additional, Van Holsbeke, C., additional, Van Huffel, S., additional, and Timmerman, D., additional

Published
2009
Full Text
View/download PDF

181. OC05.01: Predicting ovarian malignancy if simple rules are not applicable

Author

Timmerman, D., primary, Ameye, L., additional, Fischerova, D., additional, Epstein, E., additional, Melis, G. B., additional, Guerriero, S., additional, Van Holsbeke, C., additional, Savelli, L., additional, Fruscio, R., additional, Lissoni, A. A., additional, Testa, A., additional, Veldman, J., additional, Vergote, I., additional, Van Huffel, S., additional, Bourne, T., additional, and Valentin, L. I., additional

Published
2009
Full Text
View/download PDF

182. OC25.05: Adjusting prediction models for ovarian tumor classification to new clinical settings

Author

De Clercq, L., primary, Van Calster, B., additional, Van Holsbeke, C., additional, Czekierdowski, A., additional, Guerriero, S., additional, Savelli, L., additional, Franchi, D., additional, Fischerova, D., additional, Zhang, J., additional, Epstein, E., additional, Valentin, L. I., additional, Testa, A., additional, Van Huffel, S., additional, and Timmerman, D., additional

Published
2009
Full Text
View/download PDF

189. OC21.02: Adnexal masses difficult to classify as benign or malignant using subjective evaluation of ultrasound findings: logistic regression models do not help

Author

Valentin, L. I., primary, Ameye, L., additional, Savelli, L., additional, Fruscio, R., additional, Leone, F., additional, Czekierdowski, A., additional, Lissoni, A. A., additional, Fischerova, D., additional, Guerriero, S., additional, Van Holsbeke, C., additional, Van Huffel, S., additional, and Timmerman, D., additional

Published
2009
Full Text
View/download PDF

190. OC154: Prospective external validation of an ultrasound scoring system to differentiate benign from malignant masses in specific subgroups of adnexal tumors

Author

Valentin, L., primary, Ameye, L., additional, Fruscio, R., additional, Van Holsbeke, C., additional, Czekierdowski, A., additional, Guerriero, S., additional, Colombo, N., additional, Fischerova, D., additional, Jingzhang, B.C.H., additional, Van Huffel, S., additional, Testa, A. C., additional, and Timmerman, D., additional

Published
2008
Full Text
View/download PDF

192. OP17.01: Prospective comparison of one‐step and two‐step models for the classification of adnexal masses as benign or malignant

Author

Daemen, A., primary, Van Holsbeke, C., additional, Gevaert, O., additional, Fruscio, R., additional, Guerriero, S., additional, Czekierdowski, A., additional, Valentin, L., additional, Savelli, L., additional, Testa, A. C., additional, Fischerova, D., additional, Bourne, T., additional, Vergote, I., additional, De Moor, B., additional, and Timmerman, D., additional

Published
2008
Full Text
View/download PDF

193. OC162: Presence of acoustic streaming in different types of adnexal masses

Author

Van Holsbeke, C., primary, Guerriero, S., additional, Van Belle, V., additional, Czekierdowski, A., additional, Ombelet, W., additional, Valentin, L., additional, Fischerova, D., additional, Paladini, D., additional, Jingzhang, Z., additional, Jurkovic, D., additional, Bourne, T., additional, and Timmerman, D., additional

Published
2008
Full Text
View/download PDF

196. OC147: Confirming the limited role of CA-125 for adnexal mass diagnosis

Author

Van Calster, B., primary, Van Holsbeke, C., additional, Fruscio, R., additional, Lissoni, A. A., additional, Guerriero, S., additional, Valentin, L., additional, Czekierdowski, A., additional, Colombo, N., additional, de Jonge, E., additional, Fischerova, D., additional, Testa, A. C., additional, Van Huffel, S., additional, Bourne, T., additional, and Timmerman, D., additional

Published
2008
Full Text
View/download PDF

197. OC146: Multicenter prospective testing to predict malignancy in adnexal masses using Bayesian network models

Author

Gevaert, O., primary, Van Holsbeke, C., additional, Fruscio, R., additional, Guerriero, S., additional, Czekierdowski, A., additional, Savelli, L., additional, Testa, A. C., additional, Fischerova, D., additional, Jurkovic, D., additional, Bourne, T., additional, Neven, P., additional, Valentin, L., additional, De Moor, B., additional, and Timmerman, D., additional

Published
2008
Full Text
View/download PDF

198. OC144: Prospective evaluation of logistic regression models to predict malignancy of adnexal masses prior to surgery

Author

Van Calster, B., primary, Van Holsbeke, C., additional, Fruscio, R., additional, Guerriero, S., additional, Czekierdowski, A., additional, Valentin, L., additional, Savelli, L., additional, Testa, A. C., additional, Colombo, N., additional, Fischerova, D., additional, Zhang, J., additional, Jurkovic, D., additional, Van Huffel, S., additional, Bourne, T., additional, and Timmerman, D., additional

Published
2008
Full Text
View/download PDF

199. OC149: The ability of four ultrasound methods to discriminate between benign and malignant tumors considered difficult to classify by ultrasound examiners

Author

Valentin, L., primary, Ameye, L., additional, Savelli, L., additional, Van Holsbeke, C., additional, Fruscio, R., additional, Testa, A. C., additional, Fischerova, D., additional, Van Huffel, S., additional, Paladini, D., additional, Amant, F., additional, Jurkovic, D., additional, and Timmerman, D., additional

Published
2008
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results